Biomarker-based risk model to predict persistent multiple organ dysfunction after congenital heart surgery
AssigneeChildren's Hospital Medical Center
InventorHector R. Wong
Life of this patent
Estimating the term…
Loading patent…
AssigneeChildren's Hospital Medical Center
InventorHector R. Wong
Estimating the term…
Methods and compositions disclosed herein generally relate to methods of identifying, validating, and measuring clinically relevant, quantifiable biomarkers of diagnostic and therapeutic responses for blood, vascular, cardiac, and respiratory tract dysfunction, particularly as those responses relate to persistent multiple organ dysfunction syndrome (MODS) in pediatric patients following cardiopulmonary bypass (CPB). Certain aspects of the disclosure relates to identifying one or more biomarkers associated with septic shock in pediatric patients, obtaining one or more samples from a pediatric patient following CPB, then quantifying from the sample an amount of said biomarkers, wherein the level of said biomarker correlates with a predicted outcome.
A method of classifying a patient following cardiopulmonary bypass (CPB) as high risk of persistent multiple organ dysfunction syndrome (MODS), or other than high risk of persistent MODS, the method comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A diagnostic kit, test, or array comprising a reporter hybridization probe, and a capture hybridization probe specific for each of two or more mRNA, DNA, or protein biomarkers selected from the group consisting of:
-40. (canceled)
Dependencies are inferred from the claim text.